Financial Conflicts of Interest Among Oncologist Authors of Reports of Clinical Drug Trials

Cole Wayant; Erick Turner; Chase Meyer; Philip Sinnett; Matt Vassar

doi:10.1001/jamaoncol.2018.3738

Financial Conflicts of Interest Among Oncologist Authors of Reports of Clinical Drug Trials

JAMA Oncol. 2018 Oct 1;4(10):1426-1428. doi: 10.1001/jamaoncol.2018.3738.

Authors

Cole Wayant¹, Erick Turner², Chase Meyer¹, Philip Sinnett³, Matt Vassar¹

Affiliations

¹ Department of Biomedical Sciences, Oklahoma State University Center for Health Sciences, Tulsa.
² Department of Psychiatry, Oregon Health Sciences University, Portland.
³ Department of Internal Medicine, Baylor Scott & White Internal Medicine, Temple, Texas.

Abstract

This analysis investigates the prevalence of financial relationships between oncologist authors of clinical drug trials and the pharmaceutical industry and how often such financial interests are unreported.

MeSH terms

Conflict of Interest / economics*
Drug Evaluation / economics
Drug Industry / economics*
Humans
Oncologists / economics*
Periodicals as Topic / economics*
Publications / economics*